Submit Deal
All corporates
Similar corporates
Summary
Alnylam Pharmaceuticals is an RNAi therapeutics company.
Deals Overview
Market Context
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Christine Regan Lindenboom
Senior Vice President
Josh Brodsky
Director
Deals (1)
Service Providers
Relationships
Portfolio
Team
Sort
Target: ALNYLAM
Bidder: BLACKSTONE GROUP INC
7 Service Providers
53 Dealmakers
£ 1.60 B
Value
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy